PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
1.398
+0.018 (1.30%)
Apr 1, 2025, 11:23 AM CET

PCI Biotech Holding ASA Revenue

In the year 2024, PCI Biotech Holding ASA had annual revenue of 6.74M NOK with 125.25% growth. PCI Biotech Holding ASA had revenue of 3.31M in the half year ending December 31, 2024, with 39.33% growth.

Revenue
6.74M
Revenue Growth
+125.25%
P/S Ratio
7.74
Revenue / Employee
1.12M
Employees
6
Market Cap
52.18M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.74M3.75M125.25%
Dec 31, 20232.99M-1.76M-37.05%
Dec 31, 20224.75M-1.52M-24.28%
Dec 31, 20216.27M-1.10M-14.86%
Dec 31, 20207.37M-2.02M-21.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 562.60M
Nordhealth AS 537.23M
Photocure ASA 525.39M
Vistin Pharma ASA 429.50M
Hofseth BioCare ASA 265.54M
ArcticZymes Technologies ASA 108.11M
Omda AS 426.27M
Gentian Diagnostics ASA 152.07M
Revenue Rankings